Private AI for Clinical Trials

Artificial Intelligence (AI) is poised to revolutionize the clinical trial process, streamlining and accelerating the discovery of new treatments and therapies.  AI can augment intelligence for clinical teams, providing them with powerful tools that can streamline decision making.

SterlingBio is at the forefront of this innovation, offering cutting-edge solutions that leverage AI to optimize the clinical trial process. SureIntel, our advanced Private AI platform, offers centralized clinical intelligence across multiple applications, data and systems of your choice.  With SterlingBio’s SureIntel, clinical teams can access role specific and organization specific AI data through AI agent hubs, allowing protected search and query across compartmentalized data sets.  With SterlingBio’s SureIntel, you get a singular view of your data across a centralized clinical intelligence archive.   

Contact us to purchase SureIntel from SterlingBio today!